Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
federica.tomao@uniroma1.it
Federica Tomao
Ricercatore
Struttura:
DIPARTIMENTO MATERNO INFANTILE E SCIENZE UROLOGICHE
E-mail:
federica.tomao@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis
CANCERS
2024
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
JOURNAL OF GYNECOLOGIC ONCOLOGY
2024
Advances in small molecule maintenance therapies for high-grade serous ovarian cancer
EXPERT OPINION ON PHARMACOTHERAPY
2023
Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
HEALTHCARE
2023
Magnetic resonance imaging-radiomics in endometrial cancer: a systematic review and meta-analysis
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023
Sexual dysfunctions in breast cancer patients: evidence in context
SEXUAL MEDICINE REVIEWS
2023
Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer: lessons learned and future directions
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2023
The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis
REPRODUCTIVE SCIENCES
2023
Therapeutic Approaches to Vulvar Cancer: A Review of Literature
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY
2023
Pfizer-BioNtech COVID-19 vaccine in gynecologic oncology patients: a prospective cohort study
VACCINES
2022
CT-based radiomics and deep learning for BRCA mutation and progression-free survival prediction in ovarian cancer using a multicentric dataset
CANCERS
2022
Randomized phase II trial of weekly paclitaxel vs. cediranib-olaparib (continuous or intermittent schedule) in platinum-resistant high-grade epithelial ovarian cancer
GYNECOLOGIC ONCOLOGY
2022
Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients
GYNECOLOGIC AND OBSTETRIC INVESTIGATION
2022
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
JOURNAL OF GYNECOLOGIC ONCOLOGY
2022
An update on current pharmacotherapy for vulvar cancer
EXPERT OPINION ON PHARMACOTHERAPY
2022
MRI- and Histologic-Molecular-Based Radio-Genomics Nomogram for Preoperative Assessment of Risk Classes in Endometrial Cancer
CANCERS
2022
Role of circulating biomarkers in platinum-resistant ovarian cancer
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2021
Response to neoadjuvant chemotherapy in locally advanced cervical cancer: The role of immune-related factors
IN VIVO
2021
Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?
EXPERT OPINION ON DRUG SAFETY
2021
1
2
3
4
5
6
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma